◼ Archived
Health
🔮 Newsylist predicts: still trending tomorrow medium confidence — graded ✗ wrong
USC scientists just unlocked an endless supply of cancer-fighting immune cells
4sources
5articles
3velocity
+0%since first seen
41d agofirst detected
The reporting (5)
- USC Engineers Unlimited Supply of Cancer-Fighting Macrophages From Bone Marrow Tech Times · 43d ago
- A new technique could keep cancer-fighting cells coming Tech Explorist · 43d ago
- Progenitor Cells Self-Renew in Lab, Breaking Macrophage Therapy Supply Barrier Tech Times · 43d ago
- Scientists at USC have figured out how to create an army of cells to fight cancer ThePrint · 43d ago
- USC scientists just unlocked an endless supply of cancer-fighting immune cells ScienceDaily · 43d ago broke it first
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
Related trends
▲ Peaking
Health
🔮 holds
Fact check: Trump makes numerous false and misleading claims about vaccines and autism
Recent coverage fact-checks numerous false vaccine and autism claims pushed by Donald Trump.
◼ Archived
Health
🔮 fades
Why cyclospora keeps showing up in produce season after season
Utah reports nearly 50 cyclosporiasis cases, prompting local farmers to emphasize the importance of local produce.
◼ Archived
Health
🔮 holds ✗
Everyone's talking about hormone therapy for menopause. Should I be on it?
Hormone replacement therapy use has nearly doubled since 2017 amid new guidelines and widespread public discussion.
◼ Archived
Health
🔮 fades ✓
FDA approves 1st mRNA flu shot, from Moderna
The first mRNA-based influenza vaccine has received federal approval in the United States.
◼ Archived
Health
🔮 holds ✗
DNR Closes Additional Areas of Cunningham Falls State Park Following Second Beaver Attack
Two separate beaver attacks at Cunningham Falls State Park prompt additional closures in Maryland.
◼ Archived
Health
🔮 fades ✓
GLP-1 Drugs May Have a Hidden Effect on Your Eyes, Study Finds
New safety guidance and a lawsuit spotlight a possible eye‑risk link in popular GLP-1 weight‑loss drugs.